A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Clinical trial NCT05032040 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05032040
Sponsor: Xencor, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Clear Cell Carcinoma Endometrial Cancer Cervical Carcinoma Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Start date: 2022-07-21
Primary completion: 2025-10-15
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.